CompuMed

CMPD · OTC

$6.25+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About CMPD

CompuMed, Inc. engages in the provision of diagnostic telemedicine solutions to organizations. The firm's solutions provide real-time access to United States Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities. Its solutions primarily support the diagnosis and treatment of several high incidence diseases, including cardiovascular disease. The firm provides subspecialty diagnostic reading services focused on telecardiology, teleradiology and telepathology solutions. The company has established a network for remote electronic processing of electrocardiograms (ECGs), echocardiograms (Echos), ultrasound studies, X-rays and other specialty radiology. Its platform, custom tools, and infrastructure allow its customers to upload medical imaging data collected at the patient's point of care into its cloud servers. The company serves various markets, including organ donor and transplant, correctional healthcare, hospitals, and imagine centers.

Employees
0
Headquarters
Los Angeles, California
Listed
May 28, 1987
Sector
Health Care
Industry
Health Care Technology

CMPD key statistics

Market cap
8.31M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
730
Volume
100
Open price
$6.25
High today
$6.25
Low today
$6.25
52 Week high
$7.87
52 Week low
$2.67

CompuMed (CMPD) at a glance

As of Oct 20, 2026, CompuMed (CMPD) shares are priced at $6.25, giving the company a market cap of 8.31M and a price-to-earnings ratio of 0.00.

Volume so far is 100 shares, below the average of 730 shares a day.

Over the past year CompuMed has ranged from $2.67 to $7.87, and now sits 69% of the way up that range.

CompuMed met or beat analyst EPS estimates in 2 of the last 3 quarters. In Q1 FY25 it reported $0.02 per share against an estimate of $0.00.

CMPD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 3 quarters, by 28.2% on average.

  1. Q4 FY95: reported -$2.50 per share against an estimate of -$2.30
  2. Q3 FY96: reported -$1.00 per share against an estimate of -$2.30
  3. Q1 FY25: reported $0.02 per share against an estimate of $0.00

Similar companies

Companies in the same industry as CompuMed

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.